BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6421013)

  • 21. Age-related changes of antianginal effects of verapamil in patients with stable effort angina. A medium term randomized double-blind placebo controlled trial.
    Acanfora D; De Caprio L; Di Palma A; Lirato C; Parlati S; Furgi G; Guerra N; Odierna L; Nicolino A; Rengo F
    G Ital Cardiol; 1993 May; 23(5):451-8. PubMed ID: 8339870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D; De Toma L; Mangini S; Boscia F; Quagliara D; De Nicolò M; Rizzon P
    G Ital Cardiol; 1981; 11(3):364-72. PubMed ID: 7026336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
    Winsor T; Berger HJ
    Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
    Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
    Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
    Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM
    Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
    Hayata N; Araki H; Nakamura M
    Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis].
    Punzengruber C; Silberbauer K; Sinzinger H
    Z Kardiol; 1986 Nov; 75(11):676-81. PubMed ID: 3101299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sustak pharmacodynamics in effort stenocardia].
    Nazarenko VA; Nikolenko SA; Martsevich SIu; Savvateev KL; Vygodin VA
    Kardiologiia; 1982; 22(7):57-62. PubMed ID: 6810013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H
    Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris.
    Carù B; Pirelli S; Ferratini M; Gasparini M; Cattafi G; Corrada E; Pollavini P
    Eur Heart J; 1988 Jan; 9 Suppl A():105-11. PubMed ID: 3137062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nitroglycerin ointment (Nitrong) on exercise tolerance and several circulatory parameters in patients with angina pectoris.
    Nyberg G; Panfilov V
    Eur J Clin Pharmacol; 1983; 24(6):733-9. PubMed ID: 6411479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris.
    Sheridan JV; Thomas P; Routledge PA; Sheridan DJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):391-6. PubMed ID: 3107605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antianginal effects of intravenous nitroglycerin over 24 hours.
    Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
    Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible interactions of indomethacin and nitrates in angina pectoris.
    McGregor M; Crelinsten GL
    Am J Cardiol; 1984 Jan; 53(1):225-7. PubMed ID: 6419576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris.
    Kamikawa T; Kobayashi A; Yamashita T; Hayashi H; Yamazaki N
    Am J Cardiol; 1985 Aug; 56(4):247-51. PubMed ID: 3927692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.
    Gage JE; Hess OM; Murakami T; Ritter M; Grimm J; Krayenbuehl HP
    Circulation; 1986 May; 73(5):865-76. PubMed ID: 3084124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiac function during exercise in effort angina Part 2. Comparison of the effects of nitroglycerin and digitalis (author's transl)].
    Itoh K
    Nihon Naika Gakkai Zasshi; 1982 Mar; 71(3):286-94. PubMed ID: 6809866
    [No Abstract]   [Full Text] [Related]  

  • 40. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
    Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
    Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.